J. Nandhini , E. Karthikeyan , C. Jegatheshwaran , K. Vignesh , G. Muthuboopathi , S. Rajeshkumar
{"title":"抗缩纳米纤维:治疗发作性睡病的前沿药物——配方、优化和特性分析","authors":"J. Nandhini , E. Karthikeyan , C. Jegatheshwaran , K. Vignesh , G. Muthuboopathi , S. Rajeshkumar","doi":"10.1016/j.bmt.2023.10.002","DOIUrl":null,"url":null,"abstract":"<div><p>The study focuses on developing a new way to deliver the narcolepsy medication pitolisant. Electrospinning was used to make polyvinyl alcohol (PVA) and hyperbranched polyglycerol (HPG) polymers into pitolisant nanofibers (PT-NF). A design expert created the best formulation to optimise the process variables like applied voltage, distance, and feed rate. The nanofibers were characterised using scanning electron microscopy, X-ray diffraction, FT-IR, entrapment efficiency, and in-vitro drug release studies. Results showed that the optimal PT-NF formulation had an average diameter of 172 nm with an entrapment efficacy of 95 % and 92 % drug release within 45 min. HPG polymer was included in the optimised formulation, whose average fibre diameter was 118 nm with 98 % entrapment efficacy and 98 ± 2 % drug release within 30 min. These findings strongly suggest that PT nanofibers hold substantial promise as a viable alternative to conventional solid dosage forms for brain-targeted administration, especially when administered via a transdermal patch to a patient during sleep.</p></div>","PeriodicalId":100180,"journal":{"name":"Biomedical Technology","volume":"6 ","pages":"Pages 9-16"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949723X23000570/pdfft?md5=fa1c5c35b3b72e011ee68bcd166f5ffc&pid=1-s2.0-S2949723X23000570-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Pitolisant nanofibers: A promising frontier in drug delivery for narcolepsy - Formulation, optimisation, and characterization insights\",\"authors\":\"J. Nandhini , E. Karthikeyan , C. Jegatheshwaran , K. Vignesh , G. Muthuboopathi , S. Rajeshkumar\",\"doi\":\"10.1016/j.bmt.2023.10.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The study focuses on developing a new way to deliver the narcolepsy medication pitolisant. Electrospinning was used to make polyvinyl alcohol (PVA) and hyperbranched polyglycerol (HPG) polymers into pitolisant nanofibers (PT-NF). A design expert created the best formulation to optimise the process variables like applied voltage, distance, and feed rate. The nanofibers were characterised using scanning electron microscopy, X-ray diffraction, FT-IR, entrapment efficiency, and in-vitro drug release studies. Results showed that the optimal PT-NF formulation had an average diameter of 172 nm with an entrapment efficacy of 95 % and 92 % drug release within 45 min. HPG polymer was included in the optimised formulation, whose average fibre diameter was 118 nm with 98 % entrapment efficacy and 98 ± 2 % drug release within 30 min. These findings strongly suggest that PT nanofibers hold substantial promise as a viable alternative to conventional solid dosage forms for brain-targeted administration, especially when administered via a transdermal patch to a patient during sleep.</p></div>\",\"PeriodicalId\":100180,\"journal\":{\"name\":\"Biomedical Technology\",\"volume\":\"6 \",\"pages\":\"Pages 9-16\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2949723X23000570/pdfft?md5=fa1c5c35b3b72e011ee68bcd166f5ffc&pid=1-s2.0-S2949723X23000570-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomedical Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2949723X23000570\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Technology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949723X23000570","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pitolisant nanofibers: A promising frontier in drug delivery for narcolepsy - Formulation, optimisation, and characterization insights
The study focuses on developing a new way to deliver the narcolepsy medication pitolisant. Electrospinning was used to make polyvinyl alcohol (PVA) and hyperbranched polyglycerol (HPG) polymers into pitolisant nanofibers (PT-NF). A design expert created the best formulation to optimise the process variables like applied voltage, distance, and feed rate. The nanofibers were characterised using scanning electron microscopy, X-ray diffraction, FT-IR, entrapment efficiency, and in-vitro drug release studies. Results showed that the optimal PT-NF formulation had an average diameter of 172 nm with an entrapment efficacy of 95 % and 92 % drug release within 45 min. HPG polymer was included in the optimised formulation, whose average fibre diameter was 118 nm with 98 % entrapment efficacy and 98 ± 2 % drug release within 30 min. These findings strongly suggest that PT nanofibers hold substantial promise as a viable alternative to conventional solid dosage forms for brain-targeted administration, especially when administered via a transdermal patch to a patient during sleep.